Evolve is a specialized intellectual property firm focused exclusively on the pharmaceutical and biotechnology sectors, offering tailored IP strategy services that combine deep scientific expertise with commercial insight. The firm stands out for its flexible, commercially-focused approach and its team’s extensive experience in both private practice and in-house settings, providing clients with practical and personable service.
Evolve’s approach integrates scientific knowledge with strategic business acumen to help clients at every stage of development—from startups to established pharmaceutical companies—realize the full potential of their innovations. The firm is particularly known for its fractional in-house service, which offers experienced IP leadership on a flexible, cost-effective basis, seamlessly integrating with existing teams to manage day-to-day IP needs while aligning strategy with overarching business goals.
Services Offered
- Pharmaceutical IP
- Biotechnology IP
- Biologics IP
- Cell & gene therapies IP
- AI drug discovery IP
- Chemistry-related IP
- Fractional in-house IP services
- International IP counsel
- Patent portfolio management
- Strategic IP planning
- Due diligence for investors
- Formalities
- Freedom to operate (FTO) analysis
- Loss of exclusivity considerations
- Patent prosecution
Evolve serves clients globally, with a focus on the pharmaceutical and biotechnology industries, including sectors such as traditional pharmaceuticals, biologics, cell and gene therapy, and AI-driven drug discovery. The firm is regulated by the Intellectual Property Regulation Board (IPReg) and maintains a strong reputation for being nimble, responsive, and strategically adept in complex IP matters.
